Cite
Glycoproteomics revealed novel N-glycosylation biomarkers for early diagnosis of lung adenocarcinoma cancers
MLA
Kai Fang, et al. “Glycoproteomics Revealed Novel N-Glycosylation Biomarkers for Early Diagnosis of Lung Adenocarcinoma Cancers.” Clinical Proteomics, vol. 19, no. 1, Aug. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d44ae3b5c278e32eabca8a2302a81dc4&authtype=sso&custid=ns315887.
APA
Kai Fang, Qin Long, Zhonghua Liao, Chaoyu Zhang, & Zhiqiang Jiang. (2022). Glycoproteomics revealed novel N-glycosylation biomarkers for early diagnosis of lung adenocarcinoma cancers. Clinical Proteomics, 19(1).
Chicago
Kai Fang, Qin Long, Zhonghua Liao, Chaoyu Zhang, and Zhiqiang Jiang. 2022. “Glycoproteomics Revealed Novel N-Glycosylation Biomarkers for Early Diagnosis of Lung Adenocarcinoma Cancers.” Clinical Proteomics 19 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d44ae3b5c278e32eabca8a2302a81dc4&authtype=sso&custid=ns315887.